Polychlorinated biphenyl 77 augments angiotensin II-induced atherosclerosis and abdominal aortic aneurysms in male apolipoprotein E deficient mice

Toxicology and Applied Pharmacology

Volumn 257, Issue 1, 2011, Pages 148-154

  Arsenescu, Violeta ^a   Arsenescu, Razvan ^a   Parulkar, Madhura ^a   Karounos, Michael ^a   Zhang, Xuan ^a   Baker, Nicki ^a   Cassis, Lisa A ^a  

^a UNIVERSITY OF KENTUCKY   (United States)

Author keywords

Aneurysm; Angiotensin; Aryl Hydrocarbon receptor ligand; Atherosclerosis; Polychlorinated biphenyl

Indexed keywords

ADIPONECTIN; ANGIOTENSIN II; APOLIPOPROTEIN E; INTERLEUKIN 1BETA; MESSENGER RNA; MONOCYTE CHEMOTACTIC PROTEIN 1; POLYCHLORINATED BIPHENYL 77; POLYCHLORINATED BIPHENYL DERIVATIVE; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG;

ABDOMINAL AORTA ANEURYSM; ADIPOSE TISSUE; ANGIOCARDIOGRAPHY; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; AORTA ARCH; AORTA ATHEROSCLEROSIS; ARTERY DIAMETER; ARTICLE; BODY WEIGHT; CHOLESTEROL BLOOD LEVEL; CONTROLLED STUDY; IN VIVO STUDY; MALE; MOUSE; NONHUMAN; SYSTOLIC BLOOD PRESSURE;

ANGIOTENSIN II; ANIMALS; AORTIC ANEURYSM, ABDOMINAL; APOLIPOPROTEINS E; ATHEROSCLEROSIS; BLOOD PRESSURE; DRUG SYNERGISM; MALE; MICE; MICE, INBRED C57BL; MICE, MUTANT STRAINS; POLYCHLORINATED BIPHENYLS; REAL-TIME POLYMERASE CHAIN REACTION;

MUS;

EID: 81255187821     PISSN: 0041008X     EISSN: 10960333     Source Type: Journal    
DOI: 10.1016/j.taap.2011.08.028     Document Type: Article

References (49)

1. Aggarwal S., Qamar A., Sharma V., Sharma A. Abdominal aortic aneurysm: a comprehensive review. Exp. Clin. Cardiol. 2011, 16:11-15.
2. Arsenescu V., Arsenescu R.I., King V., Swanson H., Cassis L.A. Polychlorinated biphenyl-77 induces adipocyte differentiation and proinflammatory adipokines and promotes obesity and atherosclerosis. Environ. Health Perspect. 2008, 116:761-768.
3. Arsenescu R., Arsenescu V., Zhong J., Nasser M., Melinte R., Dingle R.W., Swanson H., de Villiers W.J. Role of the xenobiotic receptor in inflammatory bowel disease. Inflamm. Bowel Dis. 2011, 17:1149-1162.
4. Barisione C., Charnigo R., Howatt D.A., Moorleghen J.J., Rateri D.L., Daugherty A. Rapid dilation of the abdominal aorta during infusion of angiotensin II detected by noninvasive high-frequency ultrasonography. J. Vasc. Surg. 2006, 44:372-376.
5. Cassis L.A., Rateri D.L., Lu H., Daugherty A. Bone marrow transplantation reveals that recipient AT1a receptor are required to initiate angiotensin II-induced atherosclerosis and aneurysms. Arterioscler. Thromb. Vasc. Biol. 2007, 27:380-386.
6. Cassis L.A., Gupte M., Thayer S., Zhang X., Charnigo R., Howatt D.A., Rateri D.L., Daugherty A. ANG II infusion promotes abdominal aortic aneurysms independent of increased blood pressure in hypercholesterolemic mice. Am. J. Physiol. Heart Circ. Physiol. 2009, 296:H1660-H1665.
7. Catalano O., Siani A. Ruptured abdominal aortic aneurysm: categorization of sonographic findings and report of 3 new signs. J. Ultrasound Med. 2005, 24:1077-1083.
8. Choi Y.J., Seelbach M.J., Pu H., Eum S.Y., Chen L., Zhang B., Hennig B., Toborek M. Polychlorinated biphenyls disrupt intestinal integrity via NADPH oxidase-induced alterations in tight junction protein expression. Environ. Health Perspect. 2010, 118:976-981.
9. Daugherty A., Cassis L.A. Mechanisms of abdominal aortic aneurysm formation. Curr. Atheroscler. Rep. 2002, 4:222-227.
10. Daugherty A., Rateri D.L. Development of experimental designs for atherosclerosis studies in mice. Methods 2005, 36:129-138.
11. Daugherty A., Manning M.W., Cassis L.A. Angiotensin II promotes atherosclerotic lesions and aneurysms in apolipoprotein E-deficient mice. J. Clin. Invest. 2000, 105:1605-1612.
12. Daugherty A., Rateri D.L., Lu H., Inagami T., Cassis L.A. Hypercholesterolemia stimulates angiotensin peptide synthesis and contributes to atherosclerosis through the AT1A receptor. Circulation 2004, 110:3849-3857.
13. Daugherty A., Rateri D.L., Cassis L.A. Role of the renin-angiotensin system in the development of abdominal aortic aneurysms in animals and humans. Ann. N. Y. Acad. Sci. 2006, 1085:82-91.
14. Daugherty A., Rateri D.L., Charo I.F., Owens A.P., Howatt D.A., Cassis L.A. Angiotensin II infusion promotes ascending aortic aneurysms: attenuation by CCR2 deficiency in apoE-/- mice. Clin. Sci. (Lond) 2010, 118:681-689.
15. Diehm N., Schmidli J., Dai-Do D., Baumgartner I. Current evidence and prospects for medical treatment of abdominal aortic aneurysms. Vasa 2005, 34:217-223.
16. Goncharov A., Haase R.F., Santiago-Rivera A., Morse G., Akwesasne Task Force on the Environment, McCaffrey R.J., Rej R., Carpenter D.O. High serum PCBs are associated with elevation of serum lipids and cardiovascular disease in a Native American population. Environ. Res. 2008, 106:226-239.
17. Goncharov A., Pavuk M., Foushee H.R., Carpenter D.O. Blood pressure in relation to concentrations of PCB7 congeners and chlorinated pesticides. Environ. Health Perspect. 2011, 119:319-325.
18. Han S.G., Eum S.Y., Toborek M., Smart E., Hennig B. Polychlorinated biphenyl-induced VCAM-1 expression is attenuated in aortic endothelial cells isolated from caveolin-1 deficient mice. Toxicol. Appl. Pharmacol. 2010, 246:74-82.
19. Hennig B., Hammock B.D., Slim R., Toborek M., Saraswathi V., Robertson L.W. PCB-induced oxidative stress in endothelial cells: modulation by nutrients. Int. J. Hyg. Environ. Health 2002, 205:95-102.
20. Hennig B., Meerarani P., Slim R., Toborek M., Daugherty A., Silverstone A.E., Robertson L.W. Proinflammatory properties of coplanar PCBs: in vitro and in vivo evidence. Toxicol. Appl. Pharmacol. 2002, 181:174-183.
21. Henriques T., Huang J., D'Souza S.S., Daugherty A., Cassis L.A. Orchidectomy, but not ovariectomy, regulates angiotensin II-induced vascular diseases in apolipoprotein E deficient mice. Endocrinology 2004, 145:3866-3872.
22. Hu D., Martinez A., Hornbuckle K.C. Discovery of a non-aroclor PCB (3,3'-dichlorobiphenyl) in Chicago air. Environ. Sci. Technol. 2006, 43:5113.
23. Jensen S. A new chemical hazard. New Sci. 1966, 32:612.
24. Kaneko H., Anzai T., Takahashi T., Kohno T., Shimoda M., Sasaki A., Shimizu H., Nagai T., Maekawa Y., Yoshimura K., Aoki H., Yoshikawa T., Okada Y., Yozu R., Ogawa S., Fukuda K. Role of vascular endothelial growth factor-A in development of abdominal aortic aneurysm. Cardiovasc. Res. 2011, 15:358-367.
25. Kanno K., Tazuma S., Nishioka T., Hyogo H., Chayama K. Angiotensin II participates in hepatic inflammation and fibrosis through MCP-1 expression. Dig. Dis. Sci. 2005, 50:942-948.
26. Kent K.C., Zwolak R.M., Egorova N.N., Riles T.S., Manganaro A., Moskowitz A.J., Gelijns A.C., Greco G. Analysis of risk factors for abdominal aortic aneurysm in a cohort of more than 3million individuals. J. Vasc. Surg. 2010, 52:539-548.
27. Kopf P.G., Huwe J.K., Walker M.K. Hypertension, cardiac hypertrophy, and impaired vascular relaxation induced by 2,3,7,8-tetrachlorodibenzo-p-dioxin are associated with increased superoxide. Cardiovasc. Toxicol. 2008, 8:181-193.
28. Lim E.J., Smart E.J., Toborek M., Hennig B. The role of caveolin-1 in PCB77-induced eNOS phosphorylation in human-derived endothelial cells. Am. J. Physiol. Heart Circ. Physiol. 2007, 293:H3340-H3347.
29. Lim L.S., Haq N., Mahmood S., Hoeksema L. Atherosclerotic cardiovascular disease screening in adults: American College of Preventive Medicine position statement on preventive practice. Am. J. Prev. Med. 2011, 40(381). e381-e310.
30. Linton M.F., Fazio S. Macrophages, inflammation, and atherosclerosis. Int. J. Obes. Relat. Metab. Disord. 2003, 27(Suppl 3):S35-S40.
31. Long A., Bui H.T., Barbe C., Henni A.H., Journet J., Metz D., Nazeyrollas P. Prevalence of abdominal aortic aneurysm and large infrarenal aorta in patients with acute coronary syndrome and proven coronary stenosis: a prospective monocenter study. Ann. Vasc. Surg. 2010, 24:602-608.
32. Ludewig G., Esch H., Robertson L.W. Polyhalogenierte bi-und terphenyle. Hanbuch der Lebensmitteltoxikologie 2007, 1031-1094. Wiley-VCH, Weinheim. H. Dunkelberg, T. Gebel, A. Hartwig (Eds.).
33. Lund A.K., Goens M.B., Kanagy N.L., Walker M.K. Cardiac hypertrophy in aryl hydrocarbon receptor null mice is correlated with elevated angiotensin II, endothelin-1, and mean arterial blood pressure. Toxicol. Appl. Pharmacol. 2003, 193:177-187.
34. Lund A.K., Agbor L.N., Zhang N., Baker A., Zhao H., Fink G.D., Kanagy N.L., Walker M.K. Loss of the aryl hydrocarbon receptor induces hypoxemia, endothelin-1, and systemic hypertension at modest altitude. Hypertension 2008, 51:803-809.
35. Majkova Z., Layne J., Sunkara M., Morris A.J., Toborek M., Hennig B. Omega-3 fatty acid oxidation products prevent vascular endothelial cell activation by coplanar polychlorinated biphenyls. Toxicol. Appl. Pharmacol. 2011, 251:41-49.
36. Nordon I.M., Hinchliffe R.J., Loftus I.M., Thompson M.M. Pathophysiology and epidemiology of abdominal aortic aneurysms. Nat. Rev. Cardiol. 2011, 8:92-102.
37. Owens A.P., Subramanian V., Moorleghen J.J., Guo Z., McNamara C.A., Cassis L.A., Daugherty A. Angiotensin II induces a region-specific hyperplasia of the ascending aorta through regulation of inhibitor of differentiation 3. Circ. Res. 2010, 106(611-619):2010.
38. Police S.B., Thatcher S.E., Charnigo R., Daugherty A., Cassis L.A. Obesity promotes inflammation in periaortic adipose tissue and angiotensin II-induced abdominal aortic aneurysm formation. Arterioscler. Thromb. Vasc. Biol. 2009, 29:1458-1464.
39. Puga A. Perspectives on the potential involvement of the ah receptor-dioxin axis in cardiovascular disease. Toxicol. Sci. 2011, 120:256-261.
40. Rateri D.L., Howatt D.A., Moorleghen J.J., Charnigo R., Cassis L.A., Daugherty A. Prolonged infusion of angiotensin II in apoE-/- mice promotes macrophage recruitment with continued expansion of abdominal aortic aneurysm. Am. J. Pathol. 2011, 179:1542-1548.
41. Saraff K., Babamusta F., Cassis L.A., Daugherty A. Aortic dissection precedes formation of aneurysms and atherosclerosis in angiotensin II-infused, apolipoprotein E-deficient mice. Arterioscler. Thromb. Vasc. Biol. 2003, 23:1621-1626.
42. Schneider A.R., Stapleton H.M., Cornwell J., Baker J.E. Recent declines in PAH, PCB, and toxaphene levels in the northern Great Lakes as determined from high resolution sediment cores. Environ. Sci. Technol. 2001, 35:3809-3815.
43. Stolle K., Berges A., Lietz M., Lebrun S., Wallerath T. Cigarette smoke enhances abdominal aortic aneurysm formation in angiotensin II-treated apolipoprotein E-deficient mice. Toxicol. Lett. 2010, 199:403-409.
44. Toborek M., Barger S.W., Mattson M.P., Espandiari P., Robertson L.W., Hennig B. Exposure to polychlorinated biphenyls causes endothelial cell dysfunction. J. Biochem. Toxicol. 1995, 10:219-226.
45. Vogel C.F., Sciullo E., Matsumura F. Activation of inflammatory mediators and potential role of ah-receptor ligands in foam cell formation. Cardiovasc. Toxicol. 2004, 4:363-373.
46. WHO Environmental health criteria 2. Polychlorinated Biphenyls and Terphenyls 1976, 85. WHO, Geneva, Switzerland.
47. Wu D., Nishimura N., Kuo V., Fiehn O., Shahbaz S., Van Winkle L., Matsumura F., Vogel C.F. Activation of aryl hydrocarbon receptor induces vascular inflammation and promotes atherosclerosis in apolipoprotein E-/- mice. Arterioscler. Thromb. Vasc. Biol. 2011, 31:1260-1267.
48. Yiannikouris F., Gupte M., Putnam K., Cassis L.A. Adipokines and blood pressure control. Curr. Opin. Nephrol. Hypertens. 2010, 19:195-200.
49. Zhang N., Agbor L.N., Scott J.A., Zalobowski T., Elased K.M., Trujillo A., Duke M.S., Wolf V., Walsh M.T., Born J.L., Felton L.A., Wang J., Wang W., Kanagy N.L., Walker M.K. An activated renin-angiotensin system maintains normal blood pressure in aryl hydrocarbon receptor heterozygous mice but not in null mice. Biochem. Pharmacol. 2010, 80:197-204.